Literature DB >> 6200833

Kinetics of messenger accumulation coding for IFN gamma, related to modifications in the poly(A) RNA population of activated human lymphocytes.

C Vaquero, J Sanceau, P Sondermeyer, R Falcoff.   

Abstract

Exposure of human lymphocytes to a mitogen induces the appearance of newly synthesized RNAs and proteins. This study describes the changes in overall synthesis as measured by pulse labelling of PHA treated lymphocytes as well as a qualitative analysis of the protein synthetic patterns "in vivo" and "in vitro". Both the levels of RNA and protein synthesis increase drastically in PHA stimulated cells, while cultures incubated without mitogen remained at background levels. The low translational activity in control cells is not due to the absence of messengers since the extracted RNAs clearly direct the synthesis of high molecular weight proteins when translated "in vitro". A number of qualitative differences are seen in the "in vitro" translation of RNA extracted from induced and non-induced lymphocytes, although the apparent protein synthetic pattern "in vivo" remains identical. The secretion of IFN- gamma is one of the newly expressed functions in stimulated lymphocytes and therefore has been studied more detailed in a time-course of the messenger level compared to the secreted activity of the medium. A specific probe was used to quantitate in Northern blot's the accumulation of mRNA coding for IFN- gamma.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6200833      PMCID: PMC318695          DOI: 10.1093/nar/12.6.2629

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  13 in total

1.  Improved methods for purification and assay of eukaryotic messenger ribonucleic acids and ribosomes. Quantitative analysis of their interaction in a fractionated reticulocyte cell-free system.

Authors:  A Krystosek; M L Cawthon; D Kabat
Journal:  J Biol Chem       Date:  1975-08-10       Impact factor: 5.157

2.  Influence of preincubation on the development of the inhibition of protein synthesis in extracts from interferon-treated mouse L cells. Action on tRNA.

Authors:  R Falcoff; E Falcoff; J Sanceau; J A Lewis
Journal:  Virology       Date:  1978-05-15       Impact factor: 3.616

3.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

Authors:  P S Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

4.  Translational activity of messenger ribonucleic acid isolated from unstimulated and phytohaemagglutinin-activated lymphocytes.

Authors:  D M Wallace; R Jagus; C R Benzie; J E Kay
Journal:  Biochem J       Date:  1979-11-15       Impact factor: 3.857

5.  Inhibition of polypeptides synthesis by a factor isolated from ribosomes of resting human lymphocytes: studies on the mechanism of action.

Authors:  M Ferrer; O R Burrone; I D Algranati
Journal:  FEBS Lett       Date:  1980-12-01       Impact factor: 4.124

6.  Kinetics of induction and molecular size of mRNAs encoding human interleukin-2 and gamma-interferon.

Authors:  S Efrat; S Pilo; R Kaempfer
Journal:  Nature       Date:  1982-05-20       Impact factor: 49.962

7.  Expression of human immune interferon cDNA in E. coli and monkey cells.

Authors:  P W Gray; D W Leung; D Pennica; E Yelverton; R Najarian; C C Simonsen; R Derynck; P J Sherwood; D M Wallace; S L Berger; A D Levinson; D V Goeddel
Journal:  Nature       Date:  1982-02-11       Impact factor: 49.962

8.  A two-dimensional electrophoretic analysis of protein synthesis in resting and growing lymphocytes in vitro.

Authors:  E P Lester; P Lemkin; L Lipkin; H L Cooper
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

9.  Translation of mRNA from phytohemagglutinin-stimulated human lymphocytes: characterization of interferon mRNAs.

Authors:  C Vaquero; J Sancéau; L Catinot; G Andreu; E Falcoff; R Falcoff
Journal:  J Interferon Res       Date:  1982

10.  Translation of lymphocyte mRNA into biologically-active Interleukin 2 in oocytes.

Authors:  R C Bleackley; B Caplan; C Havele; R G Ritzel; T R Mosmann; J J Farrar; V Paetkau
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

View more
  8 in total

1.  Regulation of the multiple promoters of the human aldolase A gene: response of its two ubiquitous promoters to agents promoting cell proliferation.

Authors:  S Gautron; P Maire; V Hakim; A Kahn
Journal:  Nucleic Acids Res       Date:  1991-02-25       Impact factor: 16.971

2.  Undermethylation of interferon-gamma gene in human T cell lines and normal T lymphocytes.

Authors:  R Fukunaga; M Matsuyama; H Okamura; K Nagata; S Nagata; Y Sokawa
Journal:  Nucleic Acids Res       Date:  1986-06-11       Impact factor: 16.971

3.  Intracellular human gamma-interferon triggers an antiviral state in transformed murine L cells.

Authors:  J Sancéau; P Sondermeyer; F Béranger; R Falcoff; C Vaquero
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

4.  Transcriptional and post-transcriptional regulation of TcR, CD4 and CD8 gene expression during activation of normal human T lymphocytes.

Authors:  F Paillard; G Sterkers; C Vaquero
Journal:  EMBO J       Date:  1990-06       Impact factor: 11.598

5.  Cellular and molecular mechanisms for reduced interleukin 4 and interferon-gamma production by neonatal T cells.

Authors:  D B Lewis; C C Yu; J Meyer; B K English; S J Kahn; C B Wilson
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

6.  Down-regulation of lck mRNA by T cell activation involves transcriptional and post-transcriptional mechanisms.

Authors:  F Paillard; C Vaquero
Journal:  Nucleic Acids Res       Date:  1991-09-11       Impact factor: 16.971

7.  Superinduction of the human gene encoding immune interferon.

Authors:  M A Lebendiker; C Tal; D Sayar; S Pilo; A Eilon; Y Banai; R Kaempfer
Journal:  EMBO J       Date:  1987-03       Impact factor: 11.598

8.  Helper or cytolytic functions can be selectively induced in bifunctional T cell clones.

Authors:  A Eljaafari; C Vaquero; J L Teillaud; G Bismuth; C Hivroz; I Dorval; A Bernard; G Sterkers
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.